Omiganan Completed Phase 3 Trials for Rosacea Treatment

IndicationsStatusPurposePhase
CompletedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT02576847Study to Evaluate the Long-term Safety of a Once-Daily Omiganan Topical Gel
NCT02576860Study to Evaluate the Safety and Efficacy of a Once-Daily CLS001 Topical Gel Versus Vehicle
NCT02547441Study to Evaluate the Safety and Efficacy of a Once-Daily CLS001 Topical Gel Versus Vehicle